In this regard, several studies have investigated different parameters and nomograms based on inflammation and various hematological variables in order to predict the prognosis of NSCLC patients such as the neutrophil/lymphocyte ratio [44], the thrombocyte/lymphocyte ratio [45], the C-reaction protein-to-albumin ratio [46] and the systemic immune inflammation index [47]. Here, ALB is linked to non-small cell lung carcinoma.